Search Results - "CRIPPA, Alexandre"

Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review by Dos Santos, Rafael G, Hallak, Jaime E C, Crippa, José Alexandre S

“…Cannabis can synthetize more than 400 compounds, including terpenes, flavonoids, and more than 100 phytocannabinoids. The main phytocannabinoids are…”
Get more information

The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network by Palhano-Fontes, Fernanda, Andrade, Katia C, Tofoli, Luis F, Santos, Antonio C, Crippa, Jose Alexandre S, Hallak, Jaime E C, Ribeiro, Sidarta, de Araujo, Draulio B

“…The experiences induced by psychedelics share a wide variety of subjective features, related to the complex changes in perception and cognition induced by this…”
Get full text

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study by Sanches, Rafael Faria, de Lima Osório, Flávia, Dos Santos, Rafael G, Macedo, Ligia R H, Maia-de-Oliveira, João Paulo, Wichert-Ana, Lauro, de Araujo, Draulio Barros, Riba, Jordi, Crippa, José Alexandre S, Hallak, Jaime E C

“…Ayahuasca is an Amazonian botanical hallucinogenic brew which contains dimethyltryptamine, a 5-HT2A receptor agonist, and harmine, a monoamine-oxidase A…”
Get full text

Safety and side effects of cannabidiol, a Cannabis sativa constituent by Bergamaschi, Mateus Machado, Queiroz, Regina Helena Costa, Zuardi, Antonio Waldo, Crippa, José Alexandre S

“…Cannabidiol (CBD), a major nonpsychotropic constituent of Cannabis, has multiple pharmacological actions, including anxiolytic, antipsychotic, antiemetic and…”
Get more information

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial by Chagas, Marcos Hortes N, Zuardi, Antonio W, Tumas, Vitor, Pena-Pereira, Márcio Alexandre, Sobreira, Emmanuelle T, Bergamaschi, Mateus M, dos Santos, Antonio Carlos, Teixeira, Antonio Lucio, Hallak, Jaime EC, Crippa, José Alexandre S

“…Introduction: Parkinson’s disease (PD) has a progressive course and is characterized by the degeneration of dopaminergic neurons. Although no neuroprotective…”
Get full text

Fifty years of research on cannabidiol (CBD) as an anticonvulsant: The legacy of Brazilian groups by Zuardi, Antonio Waldo, Crippa, José Alexandre

Get full text

Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder by Bolsoni, Lívia Maria, Crippa, José Alexandre S., Hallak, Jaime Eduardo Cecílio, Guimarães, Francisco Silveira, Zuardi, Antonio Waldo

“…Studies with cannabidiol (CBD) suggest that this compound has anxiolytic properties and may mediate the reconsolidation and extinction of aversive memories…”
Get full text

Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease by de Faria, Stephanie Martins, de Morais Fabrício, Daiene, Tumas, Vitor, Castro, Paula Costa, Ponti, Moacir Antonelli, Hallak, Jaime EC, Zuardi, Antonio W, Crippa, José Alexandre S, Chagas, Marcos Hortes Nisihara

“…Background: Cannabidiol (CBD) is one of the main components of Cannabis sativa and has anxiolytic properties, but no study has been conducted to evaluate the…”
Get full text

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients by BERGAMASCHI, Mateus M, COSTA QUEIROZ, Regina Helena, MARTIN-SANTOS, Rocio, CECILIO HALLAK, Jaime Eduardo, WALDO ZUARDI, Antonio, CRIPPA, Jose Alexandre S, NISIHARA CHAGAS, Marcos Hortes, GOMES DE OLIVEIRA, Danielle Chaves, SPINOSA DE MARTINIS, Bruno, KAPCZINSKI, Flávio, QUEVEDO, Joao, ROESLER, Rafael, SCHRÖDER, Nadja, NARDI, Antonio E

“…Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol (CBD), one major…”
Get full text

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation by Zuardi, Antonio Waldo, Crippa, Jose Alexandre S, Hallak, Jaime E C, Bhattacharyya, Sagnik, Atakan, Zerrin, Martin-Santos, Rocio, McGuire, Philip K, Guimarães, Francisco Silveira

“…Δ(9)-tetrahydrocannabinol (Δ(9)-THC) is the main compound of the Cannabis Sativa responsible for most of the effects of the plant. Another major constituent is…”
Get more information

Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors by Jesus, Carlos Henrique Alves, Redivo, Daiany Darlly Bello, Gasparin, Aléxia Thamara, Sotomaior, Bruna Bittencourt, de Carvalho, Milene Cristina, Genaro, Karina, Zuardi, Antonio Waldo, Hallak, Jaime Eduardo Cecílio, Crippa, José Alexandre, Zanoveli, Janaina Menezes, da Cunha, Joice Maria

“…•Cannabidiol exerts significant anti-allodynic effect in diabetic neuropathic pain.•Cannabidiol does not alter locomotor activity in diabetic animals.•5-HT1A…”
Get full text

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging by Dos Santos, Rafael G, Osório, Flávia L, Crippa, José Alexandre S, Hallak, Jaime E C

“…Serotonergic hallucinogens produce alterations of perceptions, mood, and cognition, and have anxiolytic, antidepressant, and antiaddictive properties. These…”
Get full text

Neuroimaging in social anxiety disorder: A systematic review of the literature by Freitas-Ferrari, Maria Cecilia, Hallak, Jaime E.C., Trzesniak, Clarissa, Filho, Alaor Santos, Machado-de-Sousa, João Paulo, Chagas, Marcos Hortes N., Nardi, Antonio E., Crippa, José Alexandre S.

“…Brain imaging techniques allow the in vivo evaluation of the human brain, leading to a better understanding of its anatomical, functional and metabolic…”
Get full text

Recent advances in LC-MS/MS methods to determine endocannabinoids in biological samples: Application in neurodegenerative diseases by Marchioni, Camila, de Souza, Israel Donizeti, Acquaro, Vinicius Ricardo, de Souza Crippa, José Alexandre, Tumas, Vitor, Queiroz, Maria Eugênia Costa

“…Endocannabinoids (ECs) are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors [cannabinoid receptor 1 (CB1) and cannabinoid…”
Get full text

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report by Crippa, José Alexandre S, Derenusson, Guilherme Nogueira, Ferrari, Thiago Borduqui, Wichert-Ana, Lauro, Duran, Fábio LS, Martin-Santos, Rocio, Simões, Marcus Vinícius, Bhattacharyya, Sagnik, Fusar-Poli, Paolo, Atakan, Zerrin, Filho, Alaor Santos, Freitas-Ferrari, Maria Cecília, McGuire, Philip K, Zuardi, Antonio Waldo, Busatto, Geraldo F, Hallak, Jaime Eduardo Cecílio

“…Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. However, no study to date has…”
Get full text

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years by dos Santos, Rafael G., Osório, Flávia L., Crippa, José Alexandre S., Riba, Jordi, Zuardi, Antônio W., Hallak, Jaime E. C.

“…To date, pharmacological treatments for mood and anxiety disorders and for drug dependence show limited efficacy, leaving a large number of patients suffering…”
Get full text

Altered gray matter morphometry and resting-state functional and structural connectivity in social anxiety disorder by Liao, Wei, Xu, Qiang, Mantini, Dante, Ding, Jurong, Machado-de-Sousa, João Paulo, Hallak, Jaime E.C, Trzesniak, Clarissa, Qiu, Changjian, Zeng, Ling, Zhang, Wei, Crippa, José Alexandre S, Gong, Qiyong, Chen, Huafu

“…Abstract In social anxiety disorder (SAD), impairments in limbic/paralimbic structures are associated with emotional dysregulation and inhibition of the medial…”
Get full text

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans by Bouso, José Carlos, Palhano-Fontes, Fernanda, Rodríguez-Fornells, Antoni, Ribeiro, Sidarta, Sanches, Rafael, Crippa, José Alexandre S, Hallak, Jaime E.C, de Araujo, Draulio B, Riba, Jordi

“…Abstract Psychedelic agents have a long history of use by humans for their capacity to induce profound modifications in perception, emotion and cognitive…”
Get full text

Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities by Sampedro, Frederic, de la Fuente Revenga, Mario, Valle, Marta, Roberto, Natalia, Domínguez-Clavé, Elisabet, Elices, Matilde, Luna, Luís Eduardo, Crippa, José Alexandre S, Hallak, Jaime E C, de Araujo, Draulio B, Friedlander, Pablo, Barker, Steven A, Álvarez, Enrique, Soler, Joaquim, Pascual, Juan C, Feilding, Amanda, Riba, Jordi

“…Abstract Background Ayahuasca is a plant tea containing the psychedelic 5-HT2A agonist N,N-dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute…”
Get full text

Cannabis and anxiety: a critical review of the evidence by Crippa, José Alexandre, Zuardi, Antonio Waldo, Martín-Santos, Rocio, Bhattacharyya, Sagnik, Atakan, Zerrin, McGuire, Philip, Fusar-Poli, Paolo

“…Background Anxiety reactions and panic attacks are the acute symptoms most frequently associated with cannabis use. Understanding the relationship between…”
Get full text